Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.
Saved in:
| Title: | Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors. |
|---|---|
| Authors: | Smith DC; University of Michigan, 1500 E Medical Center Drive SPC 5913, Ann Arbor, MI, 48109, USA. dcsmith@med.umich.edu., Powderly J; Carolina BioOncology Institute, Huntersville, NC, USA., Lee JJ; University of Pittsburgh, Pittsburgh, PA, USA., Shepard DR; Cleveland Clinic Foundation, Cleveland, OH, USA., Wallin J; Eli Lilly and Company, Solna, Sweden., Chaudhary A; Eli Lilly and Company, Indianapolis, IN, USA., Chao GY; Eli Lilly and Company, Indianapolis, IN, USA., Ng WT; Eil Lilly-NUS, Singapore, Singapore., Mitchell MI; Eli Lilly and Company, Windlesham, Surrey, UK., Grau G; Eli Lilly and Company, Bad Homburg, Germany., Kurek R; Eli Lilly and Company, Bad Homburg, Germany., LoRusso P; Yale University, New Haven, CT, USA. |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Aug; Vol. 78 (2), pp. 271-80. Date of Electronic Publication: 2016 Jun 16. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1432-0843 |
|---|---|
| DOI: | 10.1007/s00280-016-3074-y |
